Goldman Sachs Group Inc Sutro Biopharma, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,746,268 shares of STRO stock, worth $3.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,746,268
Previous 1,049,372 66.41%
Holding current value
$3.51 Million
Previous $3.07 Million 96.55%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$2.88 - $5.01 $2.01 Million - $3.49 Million
696,896 Added 66.41%
1,746,268 $6.04 Million
Q2 2024

Aug 13, 2024
BUY
$2.92 - $5.33 $720,180 - $1.31 Million
246,637 Added 30.72%
1,049,372 $3.07 Million
Q1 2024

May 15, 2024
SELL
$3.27 - $5.65 $843,159 - $1.46 Million
-257,847 Reduced 24.31%
802,735 $4.54 Million
Q4 2023

Feb 13, 2024
SELL
$2.07 - $4.54 $63,774 - $139,872
-30,809 Reduced 2.82%
1,060,582 $4.55 Million
Q3 2023

May 14, 2024
BUY
$3.29 - $4.9 $101,361 - $150,964
30,809 Added 2.9%
1,091,391 $3.79 Million
Q3 2023

Nov 14, 2023
SELL
$3.29 - $4.9 $24,619 - $36,666
-7,483 Reduced 0.68%
1,091,391 $3.79 Million
Q2 2023

May 14, 2024
SELL
$4.25 - $5.88 $1.71 Million - $2.36 Million
-401,739 Reduced 26.77%
1,098,874 $5.11 Million
Q2 2023

Aug 14, 2023
SELL
$4.25 - $5.88 $1.71 Million - $2.36 Million
-401,739 Reduced 26.77%
1,098,874 $5.11 Million
Q1 2023

May 14, 2024
BUY
$4.48 - $8.45 $1.9 Million - $3.58 Million
423,145 Added 39.27%
1,500,613 $6.93 Million
Q1 2023

May 11, 2023
BUY
$4.48 - $8.45 $1.9 Million - $3.58 Million
423,145 Added 39.27%
1,500,613 $6.93 Million
Q4 2022

May 14, 2024
BUY
$5.41 - $8.08 $740,612 - $1.11 Million
136,897 Added 14.55%
1,077,468 $8.71 Million
Q4 2022

Feb 13, 2023
BUY
$5.41 - $8.08 $740,612 - $1.11 Million
136,897 Added 14.55%
1,077,468 $8.71 Million
Q3 2022

May 14, 2024
BUY
$5.17 - $7.11 $2.25 Million - $3.09 Million
434,511 Added 85.86%
940,571 $5.22 Million
Q3 2022

Nov 10, 2022
BUY
$5.17 - $7.11 $2.25 Million - $3.09 Million
434,511 Added 85.86%
940,571 $5.22 Million
Q2 2022

May 14, 2024
SELL
$3.41 - $8.95 $1.89 Million - $4.96 Million
-554,522 Reduced 52.28%
506,060 $2.64 Million
Q2 2022

Aug 15, 2022
BUY
$3.41 - $8.95 $353,545 - $927,927
103,679 Added 25.77%
506,060 $2.64 Million
Q1 2022

May 16, 2022
BUY
$7.78 - $15.31 $309,861 - $609,766
39,828 Added 10.99%
402,381 $3.31 Million
Q4 2021

Feb 14, 2022
BUY
$14.25 - $23.53 $518,643 - $856,397
36,396 Added 11.16%
362,553 $5.4 Million
Q3 2021

Nov 10, 2021
BUY
$16.88 - $22.38 $5.51 Million - $7.3 Million
326,157 New
326,157 $6.16 Million

Others Institutions Holding STRO

# of Institutions
137
Shares Held
62.4M
Call Options Held
77.1K
Put Options Held
31.4K
View Full List

About SUTRO BIOPHARMA, INC.

STRO Quotes by TradingView
  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $105M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email